Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Tobias Weiglein



Ludwig Maximilians University of Munich
Campus Großhadern

Tobias Weiglein, MD, MBA, is a medical oncologist at the Department of Haematology and Oncology at the Ludwig Maximilians University of Munich, Campus Großhadern, Germany.

He started his career as a medical doctor in Munich in 2010. His clinical research focuses on the treatment of malignant lymphoma, especially mantle cell lymphoma and marginal zone lymphoma. Another area of interest lies in health care economics and future care for cancer patients in less developed rural areas. In 2015 he completed his specialisation in palliative care and in 2016 received his Master’s Degree in Health and Business Administration at the Friedrich Alexander University of Nürnberg. In 2018 he completed his training on primary psychosomatic health care.

Dr Weiglein is a member of the European Society for Medical Oncology (ESMO), the German Association of Hematology and Oncology (DGHO), the German Cancer Association (DKK), the German Association of Palliative Care (DGP), the German Working Group for internal Oncology (AIO) and the Tumor-Center Munich (TZM).

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.